Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression.

J Neurochem · 2021 · PMC8359467 · PMID 32955735

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our sample collection, according to results of the ARGO study (Lovestone et al., 2015 ), tideglusib‐treated patients showed a trend toward decreased CSF P‐tau levels as compared with placebo‐treated patients that was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.